Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality

Clin Transl Sci. 2012 Jun;5(3):235-42. doi: 10.1111/j.1752-8062.2012.00403.x. Epub 2012 Mar 27.

Abstract

Phospholemman (PLM) regulates [Na(+) ](i), [Ca(2+)](i) and contractility through its interactions with Na(+)-K(+)-ATPase (NKA) and Na(+) /Ca(2+) exchanger (NCX1) in the heart. Both expression and phosphorylation of PLM are altered after myocardial infarction (MI) and heart failure. We tested the hypothesis that absence of PLM regulation of NKA and NCX1 in PLM-knockout (KO) mice is detrimental. Three weeks after MI, wild-type (WT) and PLM-KO hearts were similarly hypertrophied. PLM expression was lower but fractional phosphorylation was higher in WT-MI compared to WT-sham hearts. Left ventricular ejection fraction was severely depressed in WT-MI but significantly less depressed in PLM-KO-MI hearts despite similar infarct sizes. Compared with WT-sham myocytes, the abnormal [Ca(2+) ], transient and contraction amplitudes observed in WT-MI myocytes were ameliorated by genetic absence of PLM. In addition, NCX1 current was depressed in WT-MI but not in PLM-KO-MI myocytes. Despite improved myocardial and myocyte performance, PLM-KO mice demonstrated reduced survival after MI. Our findings indicate that alterations in PLM expression and phosphorylation are important adaptations post-MI, and that complete absence of PLM regulation of NKA and NCX1 is detrimental in post-MI animals.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Signaling
  • Cell Size
  • Heart Function Tests
  • Ion Channel Gating
  • Membrane Proteins / deficiency*
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Models, Cardiovascular
  • Myocardial Contraction / physiology*
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / metabolism*
  • Myocardial Infarction / pathology
  • Myocardial Infarction / physiopathology*
  • Myocardium / metabolism*
  • Myocardium / pathology*
  • Myocytes, Cardiac / pathology
  • Organ Size
  • Phosphoproteins / deficiency*
  • Phosphoproteins / metabolism
  • Phosphorylation
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Survival Analysis
  • Ultrasonography

Substances

  • Membrane Proteins
  • Phosphoproteins
  • phospholemman
  • Sodium-Potassium-Exchanging ATPase